Special Issue "Emerging and Re-emerging Infectious Diseases: Diagnosis and Management"
Deadline for manuscript submissions: 31 December 2023 | Viewed by 8875
Interests: infection control in hospitals; intensive care unit infections; sepsis, antimicrobial resistance and control; zoonotic diseases
Emerging infectious diseases (EIDs) are infectious diseases that have appeared and affected a population for the first time, or have existed previously but are rapidly increasing, either in terms of the number of new cases within a population, or their spread to new geographical areas. Re-emerging infectious diseases (REIDs) are infectious diseases that constituted significant health problems in a particular geographic area or globally during a previous time period, then declined greatly, but are now again becoming health problems of major importance. These diseases can easily cause epidemics and pandemics with the increasing travel, trade and mobility of people worldwide. The last pandemic has shown us that EIDs and REIDs still have a significant impact on global health security and the shaping of people’s lives.
Many EIDs and REIDs (up to 75%) have a zoonotic origin, meaning that the disease has emerged from an animal and crossed the species barrier to infect humans. However, infections due to several multi-drug resistant organisms are also in the EIDs and REIDs categories, such as vancomycin-resistant Staphylococcus aureus and Candida auris, which are considered non-zoonotic EIDs that are related to antibiotic overuse and misuse. Regardless of the source of EIDs and REIDs, the disease can spread easily when there is a microorganism that spreads from person to person and susceptible hosts in the community easily and cause epidemics and also pandemics. Early diagnosis and treatment and taking early isolation measures are important to prevent the spread of the disease.
The presently announced Special Issue entitled “Emerging and Re-emerging Infectious Diseases: Diagnosis and Management” will encompass research articles, case presentations, and literature reviews concerning the epidemiology, medical surveillance, as well as diagnostic and therapeutic challenges in EIDs and REIDs.
This Special Issue will explore, but is not restricted to, the following topics in EIDs and REIDs:
- Surveillance and diagnostics;
- Early warning response system and future pandemic preparedness;
- Advances in the diagnostics;
- Recent vaccine studies;
- Clinical evaluation and therapeutics.
We hope that the published data will contribute to scientific discussion concerning these global health security problems.
Prof. Dr. Emine Alp
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- emerging disease
- re-emerging disease
- early warning response system